|
|||||
|
|
p300 is a component of an estrogen receptor coactivator complex. |
|
| Authors: | B Hanstein R Eckner J DiRenzo S Halachmi H Liu B Searcy R Kurokawa M Brown |
| Affiliation: | Division of Neoplastic Disease Mechanisms, Dana-Farber Cancer Institute, Boston, MA 02115, USA. |
| Abstract: | |
| Keywords: | |